Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.

Saved in:
Bibliographic Details
Title: Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
Authors: Macleod D; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: david.macleod@lshtm.ac.uk., Shanaube K; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia., Skalland T; HPTN Statistical and Data Management Centre, Seattle, WA, USA., Limbada M; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia., Mandla N; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa., Bwalya J; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia., Schaap A; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia., Yang B; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa., Donnell D; HPTN Statistical and Data Management Centre, Seattle, WA, USA., Piwowar-Manning E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hoddinott G; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa., Bond V; Global Health and Development Department, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia., Moore A; FHI 360, HIV Prevention Trials Network, Durham, NC, USA., Griffith S; FHI 360, HIV Prevention Trials Network, Durham, NC, USA., Bock P; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa., Ayles H; Zambart, School of Public Health, University of Zambia, Lusaka, Zambia., Fidler S; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK., Hayes R; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Floyd S; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Corporate Authors: HPTN 071 (PopART) Study Team
Source: The lancet. HIV [Lancet HIV] 2022 Nov; Vol. 9 (11), pp. e751-e759.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3018
DOI:10.1016/S2352-3018(22)00237-5